Melexis: update on the share buy-back program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailPress release - Regulated Information
Ieper, Belgium – 30 March 2026, 17.45 hrs CET
Melexis reports the purchase of 24,000 Melexis shares on Euronext Brussels in the period from 23 March 2026 to 27 March 2026, related to the share buy-back program announced on 10 December 2025.
| Trade date | Total shares purchased | Average price (€) | Min price (€) | Max price (€) | Buyback amount (€) |
| 23/3/2026 | 5,000 | 50.67 | 48.64 | 51.75 | 253,365 |
| 24/3/2026 | 5,000 | 50.85 | 50.15 | 51.30 | 254,242 |
| 25/3/2026 | 4,500 | 53.47 | 52.40 | 54.50 | 240,606 |
| 26/3/2026 | 4,500 | 52.73 | 51.85 | 53.25 | 237,301 |
| 27/3/2026 | 5,000 | 50.95 | 50.55 | 52.20 | 254,761 |
| TOTAL | 24,000 | 51.68 | 48.64 | 54.50 | 1,240,274 |
Under the current share buy-back program for up to 850,000 shares, Melexis purchased 215,300 treasury shares.
Including 831,491 shares purchased under a previous share buy-back program, Melexis now holds 1,046,791 treasury shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
- Urban Seed Logs Record Harvest in 15th Season, Sets 2027 Focus on Building an Organization That Lasts
- The Boulder Group Arranges Sale of Net Leased Steak ’n Shake
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
